Publicacións en colaboración con investigadores/as de Institut Universitari Dexeus (2)

2021

  1. Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3391-3402

2012

  1. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial

    The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246